½ÃÀ庸°í¼­
»óǰÄÚµå
1772643

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, Á¦Ç° À¯Çüº°, µð¹ÙÀ̽º À¯Çüº°, ¿ëµµº°, À¯Çüº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)

Wearable Heart Monitoring Devices Market Size, Share, and Growth Analysis, By Product, By Device Type, By Application, By Type, By Region - Industry Forecast 2025-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â 32¾ï ´Þ·¯, 2024³â 35¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 90¾ï 2,000¸¸ ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£(2025-2032³â) CAGR 12.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ÀåÄ¡ ¼¼°è ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, °Ç°­ ÀÎ½Ä Áõ°¡, ½Ç½Ã°£ ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä¿¡ ÀÇÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì¿Í ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ƯÈ÷ ³ë³âÃþ¿¡¼­ ¿þ¾î·¯ºí ±â¼ú äÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ °­È­, Ä¿³ØÆ¼µå µð¹ÙÀ̽ºÀÇ ÀÓ»óÀû ¼ö¿ë¼º È®´ë, ºñħ½ÀÀû ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ µîÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ AI ±â¹Ý ºÐ¼®°ú ºí·çÅõ½º ±â¼úÀÇ ÅëÇÕÀº ÀåÄ¡ÀÇ Á¤È®¼º°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ¹ßÀü, ¼¾¼­ÀÇ ¼ÒÇüÈ­, ÇÏÀÌÅ×Å© ±â¾÷°ú ÇコÄÉ¾î ±â¾÷ÀÇ Àü·«Àû Á¦ÈÞ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ±ÔÁ¦ À庮, °í±Þ ÀÇ·á¿ë ¿þ¾î·¯ºíÀÇ ³ôÀº ºñ¿ë µîÀÇ °úÁ¦µµ ³²¾ÆÀÖ½À´Ï´Ù.

¸ñÂ÷

¼­·Ð

  • Á¶»ç ¸ñÀû
  • Á¶»ç ¹üÀ§
  • Á¤ÀÇ

Á¶»ç ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷¿Í 1Â÷ µ¥ÀÌÅÍ ¹æ¹ý
  • ½ÃÀå ±Ô¸ð ¿¹Ãø
  • ½ÃÀå ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ

ÁÖ¿ä ¿ä¾à

  • ¼¼°è ½ÃÀå Àü¸Á
  • °ø±Þ°ú ¼ö¿ä µ¿Ç⠺м®
  • ºÎ¹®º° ±âȸ ºÐ¼®

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PorterÀÇ Five Forces ºÐ¼®

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • Áß¿ä ¼º°ø ¿äÀÎ
  • °æÀï Á¤µµ
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ½ÃÀå »ýŰè
  • ½ÃÀåÀÇ ¸Å·Â Áö¼ö(2024³â)
  • PESTEL ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ¹ë·ùüÀÎ ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±â¼ú ºÐ¼®
  • »ç·Ê ¿¬±¸
  • °í°´ ±¸¸Å Çൿ ºÐ¼®

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð : Á¦Ç°º°&CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • Àü±â ÆÞ½º ±â¹Ý Á¦Ç°
  • ±¤ÇÐ ±â¼ú¿¡ ±Ù°ÅÇÑ Á¦Ç°

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð : µð¹ÙÀ̽º À¯Çüº°&CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • Áø´Ü ¹× ¸ð´ÏÅ͸µ Àåºñ
  • Ä¡·á ±â±â

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð : ¿ëµµº°&CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • ½ºÆ÷Ã÷ ¹× ÇÇÆ®´Ï½º
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ
  • ÀçÅà ÇコÄɾî

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð : À¯Çüº°&CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • ¾×ƼºñƼ ¸ð´ÏÅÍ
  • ½º¸¶Æ® ¿öÄ¡
  • ½º¸¶Æ® ÀÇ·ù
  • ÆÐÄ¡

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð : À¯Åë ä³Îº°&CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • ¾à±¹
  • ¿Â¶óÀΠä³Î
  • ÇÏÀÌÆÛ¸¶ÄÏ

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð : ÃÖÁ¾ ¿ëµµº°&CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • ¼Ò¸Å ¾à±¹
  • º´¿ø
  • Çмú±â°ü
  • ±âŸ

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð&CAGR(2025-2032)

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï Á¤º¸

  • ÁÖ¿ä 5°³»ç ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2024³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ÃÖ±Ù ½ÃÀå µ¿Çâ
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • ±â¾÷ »ó¼¼
    • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
    • ±â¾÷ ºÎ¹®º° Á¡À¯À² ºÐ¼®
    • ¸ÅÃâ Àü³â´ëºñ ºñ±³(2022-2024³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • Medtronic(Ireland)
  • Johnson & Johnson Private Limited(U.S.)
  • Zimmer Biomet(U.S.)
  • 3 M(U.S.)
  • Smith+Nephew(U.K.)
  • Boston Scientific Corporation(U.S.)
  • Integra LifeSciences(U.S.)
  • Abbott(U.S.)
  • Stryker(U.S.)
  • CONMED Corporation(U.S.)
  • Koninklijke Philips N.V.(Netherlands)
  • Cardinal Health(U.S.)
  • NuVasive, Inc.(U.S.)
  • BIOTRONIK SE & Co KG(Germany)
  • LivaNova PLC(U.K.)
  • William Demant Holding A/S(Denmark)
  • Nurotron Biotechnology Co. Ltd.(China)
  • Sonova Holding AG(Switzerland)
  • Microport Scientific Corporation(China)
  • Globus Medical, Inc.(U.S.)
  • MED-EL(Austria)

°á·Ð°ú Á¦¾È

LSH 25.07.23

Global Wearable Heart Monitoring Devices Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.59 billion in 2024 to USD 9.02 billion by 2032, growing at a CAGR of 12.2% during the forecast period (2025-2032).

The global market for wearable heart monitoring devices is significantly influenced by the rising prevalence of cardiovascular diseases, heightened health awareness, and the demand for real-time patient monitoring. The increasing adoption of wearable technology, particularly among older populations in regions such as North America and Asia-Pacific, drives growth. Factors such as enhanced investment in digital health infrastructure, widespread clinical acceptance of connected devices, and consumer preference for non-invasive monitoring contribute to market expansion. Additionally, the integration of AI-driven analytics and Bluetooth technologies enhances device accuracy and usability. Key trends include progressive remote patient monitoring, miniaturization of sensors, and strategic collaborations among tech and healthcare entities. However, challenges persist, including data privacy concerns, regulatory hurdles, and the high cost of advanced medical-grade wearables.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Wearable Heart Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Wearable Heart Monitoring Devices Market Segments Analysis

Global Wearable Heart Monitoring Devices Market is segmented by Product, Device Type, Application, Type, Distribution Channel, End Use and region. Based on Product, the market is segmented into Electric Pulse Bases Product and Optical Technology Based Product. Based on Device Type, the market is segmented into Diagnostic and Monitoring Devices and Therapeutic Devices. Based on Application, the market is segmented into Sports and Fitness, Remote Patient Monitoring and Home Healthcare. Based on Type, the market is segmented into Activity Monitors, Smartwatches, Smart Clothing and Patches. Based on Distribution Channel, the market is segmented into Pharmacies, Online Channels and Hypermarkets. Based on End Use, the market is segmented into Retail Pharmacies, Hospitals, Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Wearable Heart Monitoring Devices Market

The demand for global wearable heart monitoring devices is primarily fueled by the increasing prevalence of cardiovascular disorders, which has led consumers and healthcare systems to prioritize early diagnosis and continuous health monitoring. Portable heart monitors, including smartwatches, ECG patches, and biosensors, offer convenient, non-invasive solutions that provide real-time tracking of heart activity. This capability allows for the timely identification of conditions such as arrhythmia and hypertension, making these devices particularly appealing for elderly individuals and patients with chronic heart issues. Their user-friendly design and adaptability further enhance their appeal across both clinical and consumer markets.

Restraints in the Global Wearable Heart Monitoring Devices Market

The Global Wearable Heart Monitoring Devices market faces significant barriers due to growing privacy concerns surrounding the management of individual health data. As the adoption of wearable technology increases, the collection of sensitive biometric information, such as ECG and heart rate, raises alarms about data security and ownership. Most of this data is stored on cloud platforms or shared with third-party applications, making it vulnerable to misuse. Compliance with stringent regulations, including privacy laws, adds an additional layer of complexity and expense, hindering product development and foreign market entry. Such issues foster distrust among consumers, potentially stalling product adoption rates.

Market Trends of the Global Wearable Heart Monitoring Devices Market

The global wearable heart monitoring devices market is witnessing a significant trend towards the integration of AI-driven personalized monitoring solutions in 2024. These advancements enable real-time, tailored cardiac insights, empowering users to actively engage with their health. By harnessing AI, these devices can swiftly identify arrhythmias and provide bespoke health alerts based on individual user data patterns. This not only enhances early detection but also fosters preventive care, contributing to an informed patient population. As consumers increasingly prioritize personalized healthcare experiences, the demand for advanced wearable heart monitoring devices is expected to grow exponentially, driving market expansion and innovation.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Wearable Heart Monitoring Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Electric Pulse Bases Product
  • Optical Technology Based Product

Global Wearable Heart Monitoring Devices Market Size by Device Type & CAGR (2025-2032)

  • Market Overview
  • Diagnostic and Monitoring Devices
  • Therapeutic Devices

Global Wearable Heart Monitoring Devices Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Sports and Fitness
  • Remote Patient Monitoring
  • Home Healthcare

Global Wearable Heart Monitoring Devices Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Activity Monitors
  • Smartwatches
  • Smart Clothing
  • Patches

Global Wearable Heart Monitoring Devices Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Pharmacies
  • Online Channels
  • Hypermarkets

Global Wearable Heart Monitoring Devices Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Retail Pharmacies
  • Hospitals
  • Academic Institutes
  • Others

Global Wearable Heart Monitoring Devices Market Size & CAGR (2025-2032)

  • North America (Product, Device Type, Application, Type, Distribution Channel, End Use)
    • US
    • Canada
  • Europe (Product, Device Type, Application, Type, Distribution Channel, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Device Type, Application, Type, Distribution Channel, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Device Type, Application, Type, Distribution Channel, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Device Type, Application, Type, Distribution Channel, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Private Limited (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith+Nephew (U.K.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CONMED Corporation (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuVasive, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (U.K.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • William Demant Holding A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nurotron Biotechnology Co. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonova Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microport Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Globus Medical, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MED-EL (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦